Comparison of the effects of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade on the evolution of spontaneous glomerular injury in male MWF/Ztm rats
- PMID: 8788596
Comparison of the effects of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade on the evolution of spontaneous glomerular injury in male MWF/Ztm rats
Abstract
The mechanism by which angiotensin-converting enzyme (ACE) inhibitors prevent proteinuria and glomerulosclerosis in experimental nephropathies is not yet clear. Experimental evidence is available that the effect of ACE inhibitors on the glomerular function depends on the inhibition of angiotensin II generation, but it is possible that inhibition of the bradykinin breakdown also plays a relevant role. To establish the mediators of the effects of ACE inhibitors in glomerular injury, we compared the effects of the ACE inhibitor lisinopril with those of a specific angiotensin receptor (AT1) antagonist (ZD7155) on the renal function in male MWF/Ztm rats. After 4 months (end of the study), the untreated animals developed hypertension and proteinuria (160 +/- 10 mm Hg and 214 +/- 92 mg/24 h, respectively). In the lisinopril- and in the ZD7155-treated rats, a comparable systolic pressure control was achieved (121 +/- 12 and 118 +/- 14 mm Hg, respectively), and proteinuria was significantly prevented (averaging only 38 +/- 23 and 30 +/- 8 mg/24h, respectively) at the end of the study. The glomerular filtration rate was comparable in control and lisinopril-treated rats and significantly increased in ZD7155-treated rats. Both treatments significantly reduced the glomerular capillary pressure and significantly increased the ultrafiltration coefficient (Kf) as compared with untreated animals. In ZD7155-treated rats the Kf was also significantly higher than in untreated animals glomerular sclerosis and tubulointerstitital damage developed. Structural changes were absent in lisinopril- and ZD7155-treated animals. These results show that the antihypertensive and renal protective effects of ACE inhibitors are shared by the angiotensin receptor antagonist. Thus, angiotensin II is the likely mediator of proteinuria and glomerulosclerosis which develop spontaneously with age in this model.
Similar articles
-
Chronic blockade of angiotensin II action prevents glomerulosclerosis, but induces graft vasculopathy in experimental kidney transplantation.J Pathol. 2001 May;194(1):122-9. doi: 10.1002/1096-9896(200105)194:1<122::AID-PATH859>3.0.CO;2-T. J Pathol. 2001. PMID: 11329151
-
Dissociation between antiproteinuric and antihypertensive effect of angiotensin converting enzyme inhibitors in rats.Am J Physiol. 1994 Dec;267(6 Pt 2):F1034-44. doi: 10.1152/ajprenal.1994.267.6.F1034. Am J Physiol. 1994. PMID: 7528985
-
Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis.Am J Kidney Dis. 1998 Mar;31(3):453-63. doi: 10.1053/ajkd.1998.v31.pm9506682. Am J Kidney Dis. 1998. PMID: 9506682
-
Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?Clin Ther. 2007 Sep;29(9):1803-24. doi: 10.1016/j.clinthera.2007.09.019. Clin Ther. 2007. PMID: 18035185 Review.
-
Reversing glomerular hypertension stabilizes established glomerular injury in renal ablation.J Hypertens Suppl. 1986 Dec;4(5):S239-41. J Hypertens Suppl. 1986. PMID: 3033177 Review.
Cited by
-
A multidrug, antiproteinuric approach to alport syndrome: a ten-year cohort study.Nephron. 2015;130(1):13-20. doi: 10.1159/000381480. Epub 2015 Apr 21. Nephron. 2015. PMID: 25895746 Free PMC article.
-
Transforming growth factor-beta1 is up-regulated by podocytes in response to excess intraglomerular passage of proteins: a central pathway in progressive glomerulosclerosis.Am J Pathol. 2002 Dec;161(6):2179-93. doi: 10.1016/s0002-9440(10)64495-1. Am J Pathol. 2002. PMID: 12466133 Free PMC article.
-
Regulation of angiotensin II type 2 receptor gene expression in the adrenal medulla by acute and repeated immobilization stress.J Endocrinol. 2012 Nov;215(2):291-301. doi: 10.1530/JOE-12-0181. Epub 2012 Aug 21. J Endocrinol. 2012. PMID: 22911895 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials
Miscellaneous